Zimmer Biomet Holdings, INC Form 4 insider transactions
NYSE
Mark Bezjak, President, Americas at Zimmer Biomet, reports the vesting of restricted stock units and subsequent share withholding for tax obligations.
NYSE
Lori Winkler, SVP and CHRO of Zimmer Biomet, reports the vesting of restricted stock units and associated tax withholding.
NYSE
Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and subsequent stock transactions.
NYSE
Rachel Ellingson, Chief Administrative Officer of Zimmer Biomet, reports the vesting of restricted stock units and subsequent tax withholding.
NYSE
Paul A. Stellato, VP, Controller & CAO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and related transactions.
NYSE
Zimmer Biomet's CEO, Ivan Tornos, reports the vesting and subsequent sale of shares to cover tax obligations related to restricted stock units.
NYSE
Executive VP and CFO of Zimmer Biomet Holdings, Suketu Upadhyay, reports the vesting of restricted stock units and subsequent tax withholding.
NYSE
Wilfred van Zuilen, Group President, EMEA at Zimmer Biomet, reports the vesting of restricted stock units and subsequent transactions involving common stock.
NYSE
Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reports the vesting and disposal of restricted stock units.
NYSE
Sang Yi, Group President of Asia Pacific at Zimmer Biomet, reports the acquisition and vesting of restricted stock units and shares acquired through employee stock purchase and dividend reinvestment.
NYSE
Lori Winkler, SVP and CHRO of Zimmer Biomet, reports the vesting of restricted stock units (RSUs) and subsequent transactions involving common stock.
NYSE
Wilfred van Zuilen, Group President, EMEA at Zimmer Biomet, reports acquisition and disposal of common stock and restricted stock units.
NYSE
CEO Ivan Tornos reports acquisition and disposal of Zimmer Biomet stock and restricted stock units.
NYSE
Executive VP and CFO of Zimmer Biomet, Suketu Upadhyay, reports acquisition and disposal of common stock and restricted stock units.
NYSE
Mark Bezjak, President, Americas at Zimmer Biomet Holdings, Inc., reports acquisition and disposal of common stock and restricted stock units.
NYSE
Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the vesting and subsequent disposition of restricted stock units and other stock transactions.
NYSE
Rachel Ellingson, Chief Administrative Officer of Zimmer Biomet, reports the vesting and subsequent transactions involving restricted stock units and common stock.
NYSE
Director Devdatt Kurdikar reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.
NYSE
Director Kolli Sreelakshmi reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.
NYSE
Director Maria Teresa Hilado reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.
NYSE
Director Arthur J. Higgins reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.
NYSE
Director Robert Hagemann reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the deferred compensation plan.
NYSE
Director Michael J. Farrell reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.
NYSE
Director Christopher Begley reports acquisition of phantom stock units under Zimmer Biomet's deferred compensation plan.
NYSE
Director Syed A. Jafry reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the company's deferred compensation plan.
NYSE
Director Louis Shapiro reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.
NYSE
Suketu Upadhyay, CFO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and related transactions.
NYSE
Director Louis Shapiro reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.
NYSE
Director Sreelakshmi Kolli reports acquiring phantom stock units in Zimmer Biomet through a deferred compensation plan.
NYSE
Director Syed A. Jafry reports acquisition of phantom stock units in Zimmer Biomet Holdings, Inc. under the company's deferred compensation plan.